Joint MRI T1 Unenhancing and Contrast-enhancing Multiple Sclerosis Lesion Segmentation with Deep Learning in OPERA Trials-Reference-Cited by-同舟云学术

Joint MRI T1 Unenhancing and Contrast-enhancing Multiple Sclerosis Lesion Segmentation with Deep Learning in OPERA Trials

Published:2021-12-14 Issue: Volume: Page:
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Krishnan Anitha Priya¹^ORCID,Song Zhuang¹,Clayton David¹^ORCID,Gaetano Laura¹^ORCID,Jia Xiaoming¹,de Crespigny Alex¹,Bengtsson Thomas¹,Carano Richard A. D.¹^ORCID

Affiliation:

1. From the Department of Product Development–Personalized HealthCare Imaging (A.P.K., Z.S., T.B., R.A.D.C.), Clinical Imaging Group, gRED (D.C., A.d.C.), and DevSci OMNI-Biomarker Development (X.J.), Genentech, 600 E Grand Ave, South San Francisco, CA 94080; and Global Product Development Medical Affairs, Neuroscience, F. Hoffmann-La Roche, Basel, Switzerland (L.G.).

Funder

Genentech

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.211528

Reference24 articles.

1. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines

2. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

3. T1 hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment